A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Clinical laboratory analysis quantifies biomarkers (glucose, electrolytes, enzymes, hormones, proteins) in patient samples to diagnose disease, guide treatment decisions, and monitor therapeutic response. Clinical analytical methods must achieve strict accuracy and precision requirements, operate reliably at physiological concentration ranges, minimize required patient sample volume, integrate with laboratory information systems for result reporting, and undergo rigorous quality tracking to ensure patient safety.
The analytical chemistry principles you have studied — calibration, detection limits, precision, accuracy — apply everywhere, but nowhere are the stakes higher than in a clinical diagnostic laboratory. When a physician orders a blood glucose test, the number that comes back directly determines whether a patient receives insulin, is diagnosed with diabetes, or is sent home. A 10% error in an industrial quality control lab might mean a batch gets retested; a 10% error in a clinical lab could mean a misdiagnosis. This context explains why clinical analytical chemistry layers additional rigor on top of the general analytical framework you already know.
Clinical biomarkers are measurable substances in blood, urine, or other biological fluids whose concentrations correlate with physiological or disease states. Glucose, sodium, potassium, creatinine, cholesterol, and liver enzymes like ALT and AST are among the most commonly measured. The analytical techniques are familiar: potentiometry for electrolytes (using the ion-selective electrodes you may have studied), spectrophotometry for enzyme activity assays, immunoassays for hormones and proteins. What distinguishes clinical methods is the operating range — these analytes exist at physiological concentrations (millimolar for glucose, micromolar for hormones), and the method must be accurate specifically within that narrow window.
A defining feature of clinical labs is the reference range — the interval of values expected in a healthy population. Results are flagged as high or low relative to this range, so the analytical method must be precise enough that normal variation in measurement does not push healthy patients into the abnormal zone or mask truly abnormal results. This is why clinical labs run quality control (QC) samples — solutions with known analyte concentrations — alongside every batch of patient samples. QC results are plotted on Levey-Jennings charts, and systematic drift or sudden shifts trigger investigation before any patient results are reported. The statistical rules governing when to reject a run (Westgard rules) are specific to clinical chemistry and exist because the cost of a wrong result is measured in patient outcomes, not dollars.
Modern clinical analyzers are highly automated platforms that can process hundreds of samples per hour, running dozens of different assays on each specimen with minimal human intervention. A single tube of blood is bar-coded, loaded onto a track, and routed to different analytical modules — one for electrolytes, one for metabolic panels, one for immunoassays. Results flow automatically into the laboratory information system (LIS), which applies reference ranges, flags abnormalities, and delivers the report to the physician. This integration of analytical chemistry with information technology and quality systems is what makes clinical diagnostics a distinct discipline — it is not just about getting the right number, but about getting the right number reliably, rapidly, and traceably for every patient, every time.